Publications by authors named "Barry Peters"

Claim this Profile
R
Re-boost immunizations with the peptide-based therapeutic HIV vaccine, Vacc-4x, restores geometric mean viral load set-point during treatment interruption.
Jürgen K Rockstroh, David Asmuth, Giuseppe Pantaleo, Bonaventura Clotet, Daniel Podzamczer, Barry Peters

PLoS One· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type 2 diabetes prevalence and its risk factors in HIV: A cross-sectional study.
Alastair D Duncan, Louise M Goff, Barry S Peters

PLoS One· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparative phase 1 clinical trial to identify anti-infective mechanisms of vitamin D in people with HIV infection.
Raskit Lachmann, Margaret A Bevan, Sangmi Kim, Nishma Patel, Catherine Hawrylowicz, Barry S Peters

AIDS· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug treatment for adults with HIV infection.
Miriam Samuel, Alan Winston, Barry Peters

BMJ· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cross-sectional randomised study of fracture risk in people with HIV infection in the probono 1 study.
Barry S Peters, Melissa Perry, Anthony S Wierzbicki, Lisa E Wolber, Glen M Blake

PLoS One· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trial.
Richard B Pollard, Jürgen K Rockstroh, Giuseppe Pantaleo, David M Asmuth, Barry Peters

Lancet Infect Dis· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung infections in the HIV-infected adult.
Raghu Raju, Barry S Peters, Ronan A M Breen

Curr Opin Pulm Med· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Background morbidity in HIV vaccine trial participants from various geographic regions as assessed by unsolicited adverse events.
Claudia Schmidt, Carol Smith, Burc Barin, Arash Bakhtyari, Pierre-Alexandre Bart, Barry Peters

Hum Vaccin Immunother· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated effector cell sensitivity to Treg-cell suppression that is not associated with reduced Th17-cell expression distinguishes HIV+ asymptomatic subjects from progressors.
Georgina S Thorborn, Laura Pomeroy, Heidi Ishohanni, Barry S Peters, Annapurna Vyakarnam

Eur J Immunol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of a 12-week course of omega-3 polyunsaturated fatty acids on lipid parameters in hypertriglyceridemic adult HIV-infected patients undergoing HAART: a randomized, placebo-controlled pilot trial.
Barry S Peters, Anthony S Wierzbicki, Graeme Moyle, Devaki Nair, Norbert Brockmeyer

Clin Ther· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How Representative Are Research Tissue Biobanks of the Local Populations? Experience of the Infectious Diseases Biobank at King's College, London, UK.
Zisis Kozlakidis, Christine Mant, Barry Peters, Frank Post, Julie Fox

Biopreserv Biobank· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement in vitamin D deficiency following antiretroviral regime change: Results from the MONET trial.
Julie Fox, Barry Peters, Manyu Prakash, Jose Arribas, Andrew Hill

AIDS Res Hum Retroviruses· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The assessment of metabolic syndrome in UK patients with HIV using two different definitions: CREATE 2 study.
Ali Elgalib, Michael Aboud, Ranjababu Kulasegaram, Caroline Dimian, Alastair Duncan, Barry S Peters

Curr Med Res Opin· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implications of the SILCAAT and ESPRIT trials and the future for HIV immunotherapy.
Barry S Peters, Miriam Samuel

J HIV Ther· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased sensitivity of CD4+ T-effector cells to CD4+CD25+ Treg suppression compensates for reduced Treg number in asymptomatic HIV-1 infection.
Georgina Thorborn, Laura Pomeroy, Heidi Isohanni, Melissa Perry, Barry Peters

PLoS One· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterosexual and homosexual partners practising unprotected sex may develop allogeneic immunity and to a lesser extent tolerance.
Cherry Kingsley, Barry Peters, Kaboutar Babaahmady, Laura Pomeroy, Durdana Rahman

PLoS One· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV, thrombotic thrombocytopaenic purpura and rituximab in a violent noncompliant patient.
Clare L Ross, Beverley J Hunt, Duncan Wyncoll, Andrew Hodgkiss, Barry Peters

Blood Coagul Fibrinolysis· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008.
B G Gazzard, Jane Anderson, Abdel Babiker, Marta Boffito, Gary Brook, Barry Peters

HIV Med· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV lipodystrophy and its metabolic consequences: implications for clinical practice.
Anthony S Wierzbicki, Scott D Purdon, Timothy C Hardman, Ranjababu Kulasegaram, Barry S Peters

Curr Med Res Opin· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of two randomized trials evaluating the safety and efficacy of indinavir, saquinavir and lopinavir in combination with low-dose ritonavir: the MaxCmin1 and 2 trials.
Ulrik S Justesen, Zoe Fox, Court Pedersen, Pedro Cahn, Jan Gerstoft, Barry Peters

Basic Clin Pharmacol Toxicol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: effects of dosage and route on safety and immunogenicity.
Barry S Peters, Walter Jaoko, Eftyhia Vardas, George Panayotakopoulos, Patricia Fast

Vaccine· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interaction between the CCR5 chemokine receptors and microbial HSP70.
Trevor Whittall, Yufei Wang, Justine Younson, Charles Kelly, Lesley Bergmeier, Barry Peters

Eur J Immunol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe osteoporosis and multiple fractures in an AIDS patient treated with short-term steroids for lymphoma: a need for guidelines.
George D Panayotakopoulos, Sarah Day, Barry S Peters, Ranjababu Kulasegaram

Int J STD AIDS· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying barriers to participation in prophylactic HIV-1 vaccine trials.
Barry S Peters

Int J STD AIDS· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dyslipidaemia and cardiovascular risk in HIV infection.
Ranjababu Kulasekaram, Barry S Peters, Anthony S Wierzbicki

Curr Med Res Opin· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis